WALTHAM, Mass., July 18, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that it has received certification from the International Organization for Standardization (ISO) for meeting the requirements of the ISO 13485:2003. ISO 13485 is internationally recognized as the quality standard for the design, development, production and sale of medical devices.
